Yacaman HIV studies 2007

University of Texas at Austin licenses nanoparticles that could prevent HIV infections

A chemical engineer at The University of Texas at Austin has developed a type of silver nanoparticle that prevents HIV from interacting with human cells. The university has licensed the anti-virus technology developed in the laboratory of Dr. Miguel Jose Yacaman to XXX. The XX-based company will begin investigating the nanoparticles' potential to serve as a new treatment for the human immunodeficiency virus that causes AIDS.


Photo thumbnail
Photo by Erin McCarley, 5/2007  
Click on photo for hi-res version.

Photo at left: Dr. Miguel Jose Yacaman with a focused ion beam machine used to prepare samples of HIV and silver nanoparticles for viewing on the electron microscope.

Photo thumbnail
Photo by Dr. Miguel Jose Yacaman  
Click on photo for hi-res version.

Photo at left: A transmission electron microscope image of HIV virus (four large objects), with silver nanoparticles on their surfaces (bright dots). The microscope visualizes objects about 1 micrometer (one millionth of a meter) in size.

Photo thumbnail
Photo by Erin McCarley, 5/2007
Click on photo for hi-res version.

Photo at left: Dr. Jose Yacaman has been studying the biological potential of nanoparticles for decades. Among his students is Reeja Jayan. The doctoral student in electrical engineering poses with gold nanoparticles displayed on a computer screen.

 

 

Photo thumbnail
Photo by Erin McCarley, 5/2007
Click on photo for hi-res version.

Photo at left: Selene Sepulveda Guzman, post-doctoral fellow in chemical engineering, also assists Dr. Yacaman with nanoparticle research. The colorful bottled materials appearing in the background are vials of ZnO nanoparticles under a UV lamp. These nanoparticles have potential application as biosensors.